Stanley-Laman Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-880
Closed -$211K 312
2025
Q2
$211K Buy
+880
New +$205K 0.03% 273
2024
Q2
Sell
-17,413
Closed -$3.91M 279
2024
Q1
$3.91M Buy
17,413
+1,552
+10% +$350K 0.55% 82
2023
Q4
$3.49M Sell
15,861
-609
-4% -$129K 0.53% 77
2023
Q3
$3.61M Sell
16,470
-512
-3% -$116K 0.62% 59
2023
Q2
$3.82M Sell
16,982
-362
-2% -$72.4K 0.63% 57
2023
Q1
$3.32M Buy
17,344
+2,494
+17% +$482K 0.59% 72
2022
Q4
$2.74M Buy
14,850
+2,355
+19% +$414K 0.52% 91
2022
Q3
$2.08M Buy
12,495
+496
+4% +$101K 0.39% 107
2022
Q2
$2.47M Buy
11,999
+1,349
+13% +$304K 0.44% 93
2022
Q1
$2.58M Buy
10,650
+808
+8% +$187K 0.36% 101
2021
Q4
$2.4M Buy
9,842
+1,195
+14% +$273K 0.28% 123
2021
Q3
$1.77M Buy
+8,647
New +$1.85M 0.23% 138

Other funds holding STE

Stanley-Laman Group's STE Position: Q3 2025 in Review

Stanley-Laman Group sold out of Steris (STE) in Q3 2025, closing a stake of 880 shares — an estimated $211K sold.

Stanley-Laman Group first reported a position in STE in Q3 2021 and held it in 12 quarters. The position peaked at $3.91M in Q1 2024. 844 funds tracked by Wall St. Rank hold STE as of Q3 2025.

  • Stanley-Laman Group reported no remaining Steris position as of Q3 2025 after selling out during the quarter.
  • Stanley-Laman Group sold 880 Steris shares in Q3 2025, an estimated $211K.
  • Stanley-Laman Group first reported a position in Steris in Q3 2021 and held it in 12 quarters.
  • Stanley-Laman Group's Steris position peaked at $3.91M in Q1 2024.
  • 844 funds tracked by Wall St. Rank held Steris as of Q3 2025.

Based on Stanley-Laman Group's 13F filing for Q3 2025, filed 22 Oct 2025.